Customized premixes are defined asdry or liquid custom blends of a wide array of nutrients, such as vitamins, minerals, amino acids, nutraceuticals, fibers, and nucleotides.
CustomIzed Nutrient Premixes Market contains market size and forecasts of CustomIzed Nutrient Premixes in global, including the following market information:
- Global CustomIzed Nutrient Premixes Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global CustomIzed Nutrient Premixes Market Sales, 2018-2023, 2023-2030, (K Tons)
Global top five CustomIzed Nutrient Premixes companies in 2022 (%)
The global CustomIzed Nutrient Premixes market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Vitamins Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CustomIzed Nutrient Premixes include ArmaGen, Inc., GlaxoSmithKline Plc, Recursion Pharmaceuticals, Inc., RegenxBio, Inc., Takeda Pharmaceutical Company Limited, Orchard Therapeutics Plc, Magenta Therapeutics, Shire Plc and Oxyrane, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CustomIzed Nutrient Premixes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CustomIzed Nutrient Premixes Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Tons)
Global CustomIzed Nutrient Premixes Market Segment Percentages, by Type, 2022 (%)
- Vitamins
- Minerals
- Amino Acids
- Nutraceuticals
- Nucleotides
Global CustomIzed Nutrient Premixes Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Tons)
Global CustomIzed Nutrient Premixes Market Segment Percentages, by Application, 2022 (%)
- Beverages
- Dairy
- Cereals
- Bakery & Confectionery
- Nutrition Products
- Dietary Supplements
- Others
Global CustomIzed Nutrient Premixes Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Tons)
Global CustomIzed Nutrient Premixes Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies CustomIzed Nutrient Premixes revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies CustomIzed Nutrient Premixes revenues share in global market, 2022 (%)
- Key companies CustomIzed Nutrient Premixes sales in global market, 2018-2023 (Estimated), (K Tons)
- Key companies CustomIzed Nutrient Premixes sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- ArmaGen, Inc.
- GlaxoSmithKline Plc
- Recursion Pharmaceuticals, Inc.
- RegenxBio, Inc.
- Takeda Pharmaceutical Company Limited
- Orchard Therapeutics Plc
- Magenta Therapeutics
- Shire Plc
- Oxyrane
- NanoMedSyn
- Juventas Therapeutics
- GenSight Biologics
- Inozyme Pharma
- ONL Therapeutics
- AngioChem
- Cabaletta Bio
Industry Market Size
